Related content

Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors

By Amato R.J.   Prow D.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 4, 2000-07 ,pp. : 134-138

Elsevier

Access to resources Recommend Favorite

Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer

By Kälkner Karl Mikael   Ullén Anders   Wersäll Peter   Cohn-Cedermark Gabriella  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 862-863

Informa Healthcare

Access to resources Recommend Favorite

Changes in the Incidence and Mortality of Testicular Cancer in Scotland with Particular Reference to the Outcome of Older Patients Treated for Non-seminomatous Germ Cell Tumours

By Hatton M.Q.F.   Paul J.   Harding M.   MacFarlane G.   Robertson A.G.   Kaye S.B.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1487-1491

Elsevier

Access to resources Recommend Favorite

Paclitaxel in Extensively Pretreated Nonseminomatous Germ Cell Tumors

By Nazario A.   Amato R.J.   Hutchinson L.   Bui C.   Ellerhorst J.   Logothetis C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 5, 1995-09 ,pp. : 184-187

Elsevier

Access to resources Recommend Favorite

Chemotherapy in Stage II Nonseminomatous Germ Cell Tumors of the Testis: The Institut Gustave Roussy Experience

By Culine S.   Theodore C.   Terrier-Lacombe M.J.   Droz J.-P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 5, 1995-09 ,pp. : 175-183

Elsevier

Access to resources Recommend Favorite